Clinical trials
Neoplasms by Site trials with unknown status
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
24 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 3 |
| 2013 | 2 |
| 2014 | 2 |
| 2016 | 2 |
| 2017 | 1 |
| 2018 | 2 |
| 2020 | 4 |
| 2021 | 1 |
| 2022 | 1 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Unknown status | 24 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Royal Marsden NHS Foundation Trust | 3 |
| Xiaoxiang Chen | 2 |
| Arno Therapeutics | 1 |
| Australian and New Zealand Urogenital and Prostate Cancer Trials Group | 1 |
| Binghe Xu | 1 |
| Blueprint Medicines Corporation | 1 |
| Concure Oncology-Breast Microseed Inc. | 1 |
| Guangzhou Medical University | 1 |
| Maria Sklodowska-Curie National Research Institute of Oncology | 1 |
| Medifocus, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Neoplasms by Site | 24 |
| Neoplasms | 21 |
| Digestive System Diseases | 9 |
| Carcinoma | 8 |
| Digestive System Neoplasms | 8 |
| Gastrointestinal Diseases | 8 |
| Gastrointestinal Neoplasms | 7 |
| Neoplasms by Histologic Type | 7 |
| Neoplasms, Glandular and Epithelial | 7 |
| Urogenital Neoplasms | 6 |
Trials
Showing 26 to 24 of 24. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.